The Claim
Apigenin activates AMPK in a dose-dependent manner in mouse 3T3-L1 adipocytes, and this activation is associated with suppression of adipogenesis, indicating that AMPK activation mediates apigenin’s anti-adipogenic effect.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
Apigenin increases AMPK activity in mouse fat cells in proportion to its concentration, and this increase coincides with reduced fat cell formation, suggesting AMPK activation is involved in this process.
See the scientific wording
Apigenin activates AMPK in a dose-dependent manner in mouse 3T3-L1 adipocytes, which is associated with suppression of adipogenesis, suggesting AMPK activation as a key mediator of apigenin’s anti-adipogenic effect.
Apigenin enters fat cells and turns on a cellular energy sensor called AMPK. When AMPK is activated, it shuts down a master switch called PPARγ that tells the cell to become a fat-storing cell. Without PPARγ, the cell stops making proteins and enzymes needed to store fat, so it cannot turn into a mature fat cell.
What the research says
1 studyStudy: Antiadipogenic effect of dietary apigenin through activation of AMPK in 3T3-L1 cells.
Apigenin, a natural compound in plants, turns on a cellular switch called AMPK in fat cells, and the more apigenin you use, the more it turns on. This switch helps stop fat cells from forming, which is exactly what the claim says.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.